These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 14596663)

  • 1. Amphotericin B lipid complex for the treatment of invasive fungal infections.
    Linden PK
    Expert Opin Pharmacother; 2003 Nov; 4(11):2099-110. PubMed ID: 14596663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liposomal amphotericin B: a review of its use as empirical therapy in febrile neutropenia and in the treatment of invasive fungal infections.
    Moen MD; Lyseng-Williamson KA; Scott LJ
    Drugs; 2009; 69(3):361-92. PubMed ID: 19275278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amphotericin B formulations: a comparative review of efficacy and toxicity.
    Hamill RJ
    Drugs; 2013 Jun; 73(9):919-34. PubMed ID: 23729001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amphotericin B and its new formulations: pharmacologic characteristics, clinical efficacy, and tolerability.
    Tiphine M; Letscher-Bru V; Herbrecht R
    Transpl Infect Dis; 1999 Dec; 1(4):273-83. PubMed ID: 11428998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amphotericin B lipid complex.
    Rapp RP; Gubbins PO; Evans ME
    Ann Pharmacother; 1997 Oct; 31(10):1174-86. PubMed ID: 9337444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amphotericin B lipid complex in pediatric patients with invasive fungal infections.
    Walsh TJ; Seibel NL; Arndt C; Harris RE; Dinubile MJ; Reboli A; Hiemenz J; Chanock SJ
    Pediatr Infect Dis J; 1999 Aug; 18(8):702-8. PubMed ID: 10462340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The lipid formulations of amphotericin B.
    Herbrecht R; Natarajan-Amé S; Nivoix Y; Letscher-Bru V
    Expert Opin Pharmacother; 2003 Aug; 4(8):1277-87. PubMed ID: 12877636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prospective and retrospective analysis of the nephrotoxicity and efficacy of lipid-based amphotericin B formulations.
    Cannon JP; Garey KW; Danziger LH
    Pharmacotherapy; 2001 Sep; 21(9):1107-14. PubMed ID: 11560200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amphotericin B colloidal dispersion.
    Patel R
    Expert Opin Pharmacother; 2000 Mar; 1(3):475-88. PubMed ID: 11249532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The experience is CLEAR.
    Chandrasekar P
    Int J Antimicrob Agents; 2006 Jun; 27 Suppl 1():31-5. PubMed ID: 16707248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Epidemiology and therapy of mycotic infections in immunocompromised host with special regard to the role of lipid formulations of amphotericin B].
    Viscoli C; Castagnola E
    Recenti Prog Med; 1999 Oct; 90(10):545-57. PubMed ID: 10592741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The current role of amphotericin B lipid complex in managing systemic fungal infections.
    Chu P; Sadullah S
    Curr Med Res Opin; 2009 Dec; 25(12):3011-20. PubMed ID: 19849324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-dose amphotericin B lipid complex vs. conventional amphotericin B for empirical antifungal therapy of neutropenic fever in patients with hematologic malignancies--a randomized, controlled trial.
    Subirà M; Martino R; Gómez L; Martí JM; Estany C; Sierra J
    Eur J Haematol; 2004 May; 72(5):342-7. PubMed ID: 15059069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of amphotericin B lipid complex in 548 children and adolescents with invasive fungal infections.
    Wiley JM; Seibel NL; Walsh TJ
    Pediatr Infect Dis J; 2005 Feb; 24(2):167-74. PubMed ID: 15702047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of liposomal amphotericin B versus an amphotericin B lipid complex on liver histopathology in patients with hematologic malignancies and invasive fungal infections: a retrospective, nonrandomized autopsy study.
    Chamilos G; Luna M; Lewis RE; Chemaly R; Raad II; Kontoyiannis DP
    Clin Ther; 2007 Sep; 29(9):1980-6. PubMed ID: 18035197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amphotericin B lipid complex in the management of invasive fungal infections in immunocompromised patients.
    Bassetti M; Aversa F; Ballerini F; Benedetti F; Busca A; Cascavilla N; Concia E; Tendas A; Di Raimondo F; Mazza P; Nosari AM; Rossi G
    Clin Drug Investig; 2011 Nov; 31(11):745-58. PubMed ID: 21888451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative analysis of amphotericin B lipid complex and liposomal amphotericin B kinetics of lung accumulation and fungal clearance in a murine model of acute invasive pulmonary aspergillosis.
    Lewis RE; Liao G; Hou J; Chamilos G; Prince RA; Kontoyiannis DP
    Antimicrob Agents Chemother; 2007 Apr; 51(4):1253-8. PubMed ID: 17261624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of amphotericin B lipid complex injection (ABLC) in bone marrow transplant recipients with life-threatening systemic mycoses.
    Wingard JR
    Bone Marrow Transplant; 1997 Feb; 19(4):343-7. PubMed ID: 9051244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacoeconomic analysis of amphotericin B lipid complex versus liposomal amphotericin B in the treatment of fungal infections.
    Kuti JL; Kotapati S; Williams P; Capitano B; Nightingale CH; Nicolau DP
    Pharmacoeconomics; 2004; 22(5):301-10. PubMed ID: 15061680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amphotericin B lipid complex therapy of experimental fungal infections in mice.
    Clark JM; Whitney RR; Olsen SJ; George RJ; Swerdel MR; Kunselman L; Bonner DP
    Antimicrob Agents Chemother; 1991 Apr; 35(4):615-21. PubMed ID: 2069367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.